查找临床试验
已按「IgA 肾病」检索，对应国际通用词 IgA nephropathy
共找到 40 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
China
年龄 18 Years – 75 Years
Everest Medicines (China) Co.,Ltd.
A Study of YKST02 in Participants With Primary IgA Nephropathy
China
年龄 18 Years – 75 Years
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 100 Years
Novartis Pharmaceuticals
Raman Spectroscopy Diagnosis of Kidney Diseases
China
年龄 不限 – 不限
Zunsong Wang
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
China
年龄 18 Years – 不限
Guangdong Hengrui Pharmaceutical Co., Ltd
Study of Ravulizumab in Pediatric Participants With Primary IgAN
United States、China、Italy、Japan、South Korea 等 7 国
年龄 2 Years – 18 Years
Alexion Pharmaceuticals, Inc.
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
United States、Australia、Hong Kong、Italy、South Korea 等 8 国
年龄 18 Years – 不限
ADARx Pharmaceuticals, Inc.
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
China
年龄 18 Years – 45 Years
Hansoh BioMedical R&D Company
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
United States、Australia、New Zealand、South Korea、Taiwan
年龄 18 Years – 60 Years
Jade Biosciences, Inc.
A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
China
年龄 18 Years – 不限
Beijing Mabworks Biotech Co., Ltd.
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
China
年龄 14 Years – 不限
Sun Yat-sen University
Nefecon and Ambrisentan in IgA Nephropathy
China
年龄 18 Years – 70 Years
The First Hospital of Jilin University